These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32168416)

  • 21. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
    Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J
    Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DS-1 Inhibits Migration and Invasion of Non-small-cell Lung Cancer Cells Through Suppression of Epithelial to Mesenchymal Transition and Integrin β1/FAK Signaling.
    Putri HE; Sritularak B; Chanvorachote P
    Anticancer Res; 2021 Jun; 41(6):2913-2923. PubMed ID: 34083282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells.
    Zhang D; Zhou Q; Huang D; He L; Zhang H; Hu B; Peng H; Ren D
    Biochem Biophys Res Commun; 2019 Jun; 513(3):594-601. PubMed ID: 30981511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
    Gui Z; Luo F; Yang Y; Shen C; Li S; Xu J
    Int J Oncol; 2017 Jan; 50(1):111-120. PubMed ID: 27878247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells.
    Nonpanya N; Prakhongcheep O; Petsri K; Jitjaicham C; Tungsukruthai S; Sritularak B; Chanvorachote P
    Anticancer Res; 2020 Sep; 40(9):4989-4999. PubMed ID: 32878787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells.
    Gao S; Tan H; Zhu N; Gao H; Lv C; Gang J; Ji Y
    Int J Oncol; 2016 Jun; 48(6):2453-60. PubMed ID: 27082253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.
    Che X; Zhan J; Zhao F; Zhong Z; Chen M; Han R; Wang Y
    Biomed Res Int; 2021; 2021():4340950. PubMed ID: 34285910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells.
    Kang N; Cao SJ; Zhou Y; He H; Tashiro S; Onodera S; Qiu F; Ikejima T
    Int J Oncol; 2015 Dec; 47(6):2045-56. PubMed ID: 26648189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiangiogenic effects of oridonin.
    Tian L; Xie K; Sheng D; Wan X; Zhu G
    BMC Complement Altern Med; 2017 Apr; 17(1):192. PubMed ID: 28376864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of hypoxia-induced epithelial mesenchymal transition by luteolin in non-small cell lung cancer cells.
    Ruan J; Zhang L; Yan L; Liu Y; Yue Z; Chen L; Wang AY; Chen W; Zheng S; Wang S; Lu Y
    Mol Med Rep; 2012 Jul; 6(1):232-8. PubMed ID: 22552526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
    Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
    Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yao WL; Ko BS; Liu TA; Liang SM; Liu CC; Lu YJ; Tzean SS; Shen TL; Liou JY
    Anticancer Agents Med Chem; 2014 Jan; 14(1):29-34. PubMed ID: 23855336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tanshinone IIA inhibits proliferation and migration by downregulation of the PI3K/Akt pathway in small cell lung cancer cells.
    Jiang Y; Bi Y; Zhou L; Zheng S; Jian T; Chen J
    BMC Complement Med Ther; 2024 Jan; 24(1):68. PubMed ID: 38297301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5.
    Wu J; Ding Y; Chen CH; Zhou Z; Ding C; Chen H; Zhou J; Chen C
    Cancer Lett; 2016 Oct; 380(2):393-402. PubMed ID: 27387452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cycloartobiloxanthone Inhibits Migration and Invasion of Lung Cancer Cells.
    Tungsukruthai S; Sritularak B; Chanvorachote P
    Anticancer Res; 2017 Nov; 37(11):6311-6319. PubMed ID: 29061814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice.
    Zhu Y; Xie L; Chen G; Wang H; Zhang R
    Pharmazie; 2007 Jun; 62(6):439-44. PubMed ID: 17663191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.
    Hsieh TC; Wijeratne EK; Liang JY; Gunatilaka AL; Wu JM
    Biochem Biophys Res Commun; 2005 Nov; 337(1):224-31. PubMed ID: 16176802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oridonin Suppresses Human Gastric Cancer Growth in Vitro and in Vivo via Inhibition of VEGF, Integrin β3, and PCNA.
    Yang Q; Ma W; Yu K; Zhang Q; Ye Z; Xia W; Li S
    Biol Pharm Bull; 2020; 43(7):1035-1045. PubMed ID: 32612067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling.
    Kou B; Shi Y; Zhou Z; Yun Y; Wu Q; Zhou J; Liu W
    Int J Med Sci; 2024; 21(4):623-632. PubMed ID: 38464825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.
    Aboubakar Nana F; Lecocq M; Ladjemi MZ; Detry B; Dupasquier S; Feron O; Massion PP; Sibille Y; Pilette C; Ocak S
    Mol Cancer Ther; 2019 Jan; 18(1):17-27. PubMed ID: 30352800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.